Yesmom, founded in 2017 and headquartered in Singapore, aims to revolutionize access to health information through its innovative at-home blood testing kits. By focusing on Digital Health, Health Care, and Women's Health, the company empowers individuals with the tools they need to make informed health decisions.
The company’s slogan, "Yesmom makes health information more accessible with at-home blood testing kits and informative digital results," encapsulates its mission. Initially targeting hormonal imbalances affecting female fertility, Yesmom provides an easy and convenient solution for consumers to obtain and understand their health data without visiting a lab or doctor's office.
While Yesmom offers promising solutions in a growing market, its last recorded funding was a Convertible Note investment from Santora Nakama in early 2017. This indicates that the company might benefit from further investment to expand its market reach and refine its offerings.